Targeting targeted therapies

被引：0
作者：
Shingler, William [1 ]
Harrop, Richard [1 ]
机构：
[1] Oxford BioMed Ltd, Medawar Ctr, Oxford OX4 4GA, England
来源：
IMMUNOTHERAPY | 2010年 / 2卷 / 06期
关键词：
ANTIGEN; 5T4; TROVAX; COLORECTAL-CANCER PATIENTS; POTENT IMMUNE-RESPONSES; METASTATIC RENAL-CANCER; GROWTH-FACTOR RECEPTOR; MONOCLONAL-ANTIBODY; INTERFERON-ALPHA; BREAST-CANCER; VACCINATION; TRIAL;
D O I：
10.2217/IMT.10.66
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：745 / 748
页数：4
相关论文
共 22 条
[1]  
Acres B, 2009, AACR ANN M DENV CO U
[2]   American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy [J].
Allegra, Carmen J. ;
Jessup, J. Milburn ;
Somerfield, Mark R. ;
Hamilton, Stanley R. ;
Hammond, Elizabeth H. ;
Hayes, Daniel F. ;
McAllister, Pamela K. ;
Morton, Roscoe F. ;
Schilsky, Richard L. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) :2091-2096
[3]   Vaccination of Renal Cell Cancer Patients with Modified Vaccinia Ankara Delivering Tumor Antigen 5T4 (TroVax) Administered with Interleukin 2: A Phase II Trial [J].
Amato, Robert J. ;
Shingler, William ;
Naylor, Stuart ;
Jac, Jaroslaw ;
Willis, James ;
Saxena, Somyata ;
Hernandez-McClain, Joan ;
Harrop, Richard .
CLINICAL CANCER RESEARCH, 2008, 14 (22) :7504-7510
[4]   Vaccination of prostate cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) - A phase 2 trial [J].
Amato, Robert J. ;
Drury, Noel ;
Naylor, Stuart ;
Jac, Jaroslaw ;
Saxena, Somya ;
Cao, Amy ;
Hernandez-McClain, Joan ;
Harrop, Richard .
JOURNAL OF IMMUNOTHERAPY, 2008, 31 (06) :577-585
[5]   Vaccination of Renal Cell Cancer Patients With Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Alone or Administered in Combination With Interferon-α (IFN-α) A Phase 2 Trial [J].
Amato, Robert J. ;
Shingler, William ;
Goonewardena, Madusha ;
de Belin, Jackie ;
Naylor, Stuart ;
Jac, Jaroslaw ;
Willis, James ;
Saxena, Somyata ;
Hernandez-McClain, Joan ;
Harrop, Richard .
JOURNAL OF IMMUNOTHERAPY, 2009, 32 (07) :765-772
[6]   Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry [J].
Chung, KY ;
Shia, J ;
Kemeny, NE ;
Shah, M ;
Schwartz, GK ;
Tse, A ;
Hamilton, A ;
Pan, D ;
Schrag, D ;
Schwartz, L ;
Klimstra, DS ;
Fridman, D ;
Kelsen, DP ;
Saltz, LB .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) :1803-1810
[7]   Translation of the Philadelphia chromosome into therapy for CML [J].
Druker, Brian J. .
BLOOD, 2008, 112 (13) :4808-4817
[8]   Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4) [J].
Elkord, Eyad ;
Dangoor, Adam ;
Burt, Deborah J. ;
Southgate, Thomas D. ;
Daayana, Sai ;
Harrop, Richard ;
Drijfhout, Jan W. ;
Sherlock, David ;
Hawkins, Robert E. ;
Stern, Peter L. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (10) :1657-1667
[9]   Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses [J].
Harrop, Richard ;
Drury, Noel ;
Shingler, William ;
Chikoti, Priscilla ;
Redchenko, Irina ;
Carroll, Miles W. ;
Kingsman, Susan M. ;
Naylor, Stuart ;
Griffiths, Richard ;
Steven, Neil ;
Hawkins, Robert E. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (07) :977-986
[10]   Vaccination of colorectal cancer patients with modified vaccinia Ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responses [J].
Harrop, Richard ;
Drury, Noel ;
Shingler, William ;
Chikoti, Priscilla ;
Redchenko, Irina ;
Carroll, Miles W. ;
Kingsman, Susan M. ;
Naylor, Stuart ;
Melcher, Alan ;
Nicholls, Joanna ;
Wassan, Harpreet ;
Habib, Nagy ;
Anthoney, Alan .
CLINICAL CANCER RESEARCH, 2007, 13 (15) :4487-4494
123